B. Riley Has Pessimistic View of Core Scientific Q1 Earnings

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Stock analysts at B. Riley decreased their Q1 2025 earnings per share (EPS) estimates for Core Scientific in a note issued to investors on Monday, April 28th. B. Riley analyst N. Giles now forecasts that the company will post earnings per share of ($0.16) for the quarter, down from their previous forecast of ($0.10). The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. B. Riley also issued estimates for Core Scientific's Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.07) EPS, Q4 2025 earnings at ($0.04) EPS, FY2025 earnings at ($0.37) EPS and FY2026 earnings at ($0.04) EPS.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.09. The business had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million.

CORZ has been the topic of several other reports. HC Wainwright reissued a "buy" rating and set a $17.00 price target on shares of Core Scientific in a research report on Tuesday, March 11th. Craig Hallum began coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 target price for the company. Cantor Fitzgerald lowered their price target on shares of Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Compass Point cut their price objective on Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a report on Tuesday, February 25th. Finally, Keefe, Bruyette & Woods initiated coverage on Core Scientific in a research note on Monday, January 27th. They issued an "outperform" rating and a $22.00 target price on the stock. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Core Scientific presently has an average rating of "Buy" and an average target price of $19.07.

Core Scientific Stock Up 2.0 %

Shares of Core Scientific stock traded up $0.18 during trading on Thursday, hitting $8.93. The stock had a trading volume of 3,791,122 shares, compared to its average volume of 15,187,955. Core Scientific has a 1 year low of $3.29 and a 1 year high of $18.63. The stock has a 50 day simple moving average of $8.02 and a 200 day simple moving average of $12.18. The company has a market capitalization of $2.63 billion, a PE ratio of -1.65 and a beta of 6.66.

Institutional Investors Weigh In On Core Scientific

Institutional investors and hedge funds have recently made changes to their positions in the company. Wellington Shields & Co. LLC acquired a new position in Core Scientific in the fourth quarter valued at about $26,000. First Horizon Advisors Inc. bought a new stake in Core Scientific during the 4th quarter worth approximately $34,000. Newbridge Financial Services Group Inc. acquired a new stake in Core Scientific during the 4th quarter valued at $42,000. Vestcor Inc bought a new position in Core Scientific in the 4th quarter valued at $66,000. Finally, Emerald Mutual Fund Advisers Trust acquired a new position in Core Scientific in the first quarter worth $38,000.

Insider Transactions at Core Scientific

In related news, Director Jordan Levy acquired 62,500 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were bought at an average price of $8.01 per share, for a total transaction of $500,625.00. Following the acquisition, the director now owns 306,887 shares in the company, valued at $2,458,164.87. This trade represents a 25.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Todd A. Becker sold 134,250 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the transaction, the director now directly owns 195,687 shares of the company's stock, valued at $2,103,635.25. This represents a 40.69 % decrease in their position. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.